Share on LinkedInShare on LinkedIn

ARTICLE · 18 JANUARY 2016

Tough PTAB Fight Ahead For Breakthrough Gene-Editing Tech

Fox Rothschild LLP
Fox Rothschild LLP
Contributor
Explore more from Fox Rothschild LLP

Gerard P. Norton, Ph.D. was featured in the Law360 article "Tough PTAB Fight Ahead For Breakthrough Gene-Editing Tech".

United StatesIntellectual Property

Gerard P. Norton, Ph.D. was featured in the Law360 article "Tough PTAB Fight Ahead For Breakthrough Gene-Editing Tech" Full text can be found in the January 14, 2016, issue, but a synopsis is below.

Billions of dollars in licensing revenue may be at stake as the University of California, Berkeley and the Massachusetts Institute of Technology and Broad Institue head to the Patent Trial and Appeal Board (PTAB) to determine who first invented the gene-editing technology known as CRISPR.

"This technology is huge. It's multibillion-dollar technology," said Fox Rothschild's Gerard Norton. "It's a game changer to be able to edit DNA."

Due to dates at which the patents were originally filed by the schools, the PTAB has declared interference which places all of the patents issued by MIT under review.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from